vTv Therapeutics KOL breakfast Nov 2017

New York, November 16, 2017

Please join vTv Therapeutics for a KOL breakfast highlighting the Alzheimer's drug discovery landscape and novel mechanisms of action.

Presentations start at 8:30 am EST (registration/breakfast at 8:00 am EDT)

 

For more information please contact Mike Biega (mbiega@troutgroup.com)

Register / Log Back in

Additional menu options can be found in the menu bar on the left or at the top.

vTv Therapeutics, Inc. VTVT
Late-stage, next Ph. 3 Alzheimer's da­ta read-out af­ter AX­ON. Azeli­ra­gon - oral, small-molecule in­hibi­tor of the Re­cep­tor for Ad­vanced Gly­ca­tion End­prod­ucts (RAGE), lies up­stream to AD patholo­gies... [more in­for­ma­tion]

Event Contact

Mike Biega
The Trout Group, LLC